I・カッパ・B型活性をコードするアデレントモノサイトに誘発された即時早期の遺伝子の特徴化
S Haskill1, A A Beg, S M Tompkins
1Lineberger Comprehensive Cancer Center, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599.
Cell
|July 8, 1991
まとめ
研究者らは,ヒト単細胞におけるNF-kappa B活動を調節する新しいタンパク質であるMAD-3を特定した. この発見は,単細胞活性化経路と炎症反応に光を当てています.
科学分野:
- 分子生物学は分子生物学である.
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
背景:
- 単細胞結合は,急速な遺伝子発現変化を誘発する.
- 核因子カッパB (NF-カッパB) は,免疫反応に関与する重要な転写因子である.
研究 の 目的:
- ヒトの単細胞結合に素早く誘発された新しい遺伝子を特定し,特徴づけること.
- 特定されたMAD-3タンパク質がNF-カッパBの活性を調節する機能を調査する.
主な方法:
- 誘導mRNAを代表するcDNAのクローニング.
- タンパク質配列分析とモチーフ識別.
- インビトロトランスレーションおよびDNA結合アッセイ.
主要な成果:
- 新しいトランスクリプトであるMAD-3がクローンされ,アンキリン繰り返しのタンパク質をコードすることが判明しました.
- MAD-3タンパク質は,NF-カッパB p50/p65複合体のDNA結合活動を特に抑制する.
- MAD-3はI・カッパ・Bタンパク質と構造的に類似している.
結論:
- MAD-3は,NF-カッパB依存転写の調節に関与するIカッパB型タンパク質です.
- MAD-3は,単細胞活性化の粘着に依存する経路に作用する.
- この発見は,免疫細胞における転写調節の理解に貢献する.
関連する概念動画
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Activators
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...


